PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Aspire Pharma Ltd
AP

Aspire Pharma Ltd

Godalming
SME

Aspire Pharma Ltd is a specialty generics pharmaceutical company based in the UK, focused on developing and supplying innovative products and medicines globally. They aim to enhance existing medicines and devices for better patient outcomes.

aspirepharma.co.uk ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£624.9m
Live
47
Buyers
9
12m
£576.3m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities1
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts47 / 61
  • Top buyers9
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Aspire Pharma LtdUpdated 13 Jul 2026

At a glance · for buyers and watchdogs

Aspire Pharma Ltd has won £624.9m across 9 public-sector buyers, with 47 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 99% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
47 of 61Live contracts
99%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 3
Product & InnovationDevelopment and supply of innovative products and medicines. ↗Research & PipelineResearch and development of new pharmaceutical products. ↗International SalesSales of pharmaceutical products in international markets. ↗
Frameworks & DPS · 1 from notices
  • NHS Framework Agreement for Branded medicines - NationalNHS England · £6.1m

Extracted automatically from aspirepharma.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 47 live · 14 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Generics Pharmaceuticals - Supply Chain Resilience
NHS England—01 Sept 2026£4.2m1.8 yrspending
NHS National Branded Interim - 1 June 2026
NHS England—01 Jun 2026£529.1m1.9 yrspending
Generic Drugs – Injections/Infusions 2
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Jul 2026£5.9m12 mopending
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£37.2m16 mopending
NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products
NHS England3360000001 Jun 2025£376k2 yrsLive
NHS National Framework for Transition products commencing 1 May 2024
NHS England3360000001 May 2024£630k17 moClosed
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024
NHS England3360000001 May 2024£11.2m4 yrsLive
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
NHS England3360000001 Jun 2024£0.023 yrsLive
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals
NHS England3360000001 May 2023£6.1m2 yrsClosed
NHS National Generic Pharmaceuticals Wave 14a
NHS England3360000001 Feb 2023£2.1m2 yrsClosed
Total live value £11.6m · mean award £10.2m1–10 of 61

Top buyers · 9 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
32 contracts
99%
since 2019
2
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
1 contract
1%
since 2026
3
Procurement and Logistics Service, Business Services Organisation
2 contracts
0%
4
The NHS Commissioning Board (operating under the name of NHS England)
5 contracts
0%
5
Northern Health and Social Care Trust NHSCT
1 contract
0%
6
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
13 contracts
0%
7
eTenderwales
1 contract
0%
8
Regional Business Services Organisation Procurement and Logistics Service
1 contract
0%
9
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
5 contracts
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire32 contracts
99%
Wales7 contracts
1%
Northern Ireland4 contracts
0%
North West5 contracts
0%
Scotland13 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Aspire Pharma Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
AP
Aspire Pharma Ltd
Yes£576.3m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m17
JA
Janssen-Cilag Ltd
Yes£117.6m16
AB
AbbVie Ltd
Yes£95.2m11
TA
Thornton and Ross Ltd
Yes£72.5m9
AC
ACCORD-UK LTD
Yes£71.2m18
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Up to date
Next due 05 Sept 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
06828501
Status
Active
Type
Private limited
Incorporated
24 Feb 2009
Reg. office
102 High Street, Godalming, Surrey, GU7 1DS
SIC codes
46460
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • CONDON, Richard Michael — director
    Appointed 28 Apr 2023
  • BUCKLEY, Gary David — secretary
    Appointed 15 Jun 2020
  • BUCKLEY, Gary David — director
    Appointed 15 Jun 2020
  • MAY, Jonathan Charles — director
    Appointed 15 Jun 2020
  • Aphl 2 Limited — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
ASPIRE PHARMA LIMITED
06828501 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.